Trials / Completed
CompletedNCT03744585
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 450 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to describe the real-life conditions of use and exposure of cabozantinib in France in two cohorts defined by their treatment initiation period.
Conditions
Timeline
- Start date
- 2018-11-06
- Primary completion
- 2019-06-07
- Completion
- 2019-07-07
- First posted
- 2018-11-16
- Last updated
- 2019-07-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03744585. Inclusion in this directory is not an endorsement.